首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >First identification of an antigen in autoimmune idiopathic membranous nephropathy: toward targeted therapy?
【24h】

First identification of an antigen in autoimmune idiopathic membranous nephropathy: toward targeted therapy?

机译:自身免疫性特发性膜性肾病中抗原的首次鉴定:针对靶向治疗?

获取原文
获取原文并翻译 | 示例
           

摘要

Membranous nephropathy (MN) is the most common cause of idiopathic nephrotic syndrome in white adults, accounting for apprxo20% of cases. Although spontaneous remission occurs in about one-third of patients, approx40% of patients develop kidney failure after 10 years. Eighty percent of cases are classified as "idiopathic," to conceal our ignorance about causes, whereas apprxo20% present with associated clinical conditions, including infections, autoimmune diseases, and cancers, and are classified as having secondary disease. It generally is considered that idiopathic MN is an autoimmune disease, whereas secondary forms involve exogenous antigens, such as viral and tumoral antigens.
机译:膜性肾病(MN)是白人成年人中特发性肾病综合征的最常见原因,约占病例的20%。尽管大约三分之一的患者会自发缓解,但是大约40%的患者在10年后会出现肾衰竭。 80%的病例被归类为“特发性”,以掩盖我们对原因的无知,而约20%的病例伴有相关的临床状况,包括感染,自身免疫性疾病和癌症,并被归类为继发性疾病。通常认为特发性MN是一种自身免疫性疾病,而继发性形式则涉及外源抗原,例如病毒和肿瘤抗原。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号